FDA Investigator Chunsheng Cai, PhD
Chunsheng Cai, PhD has inspections in 2 countries as of 25 Aug 2023. Chunsheng Cai, PhD has collaborated with a combinined 1082 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
3
Last Inspection Date:
25 Aug 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
Germany,
United States of America
Co-Investigator(s):
Anh M Lac,
Anthony C Warchut,
Azza Talaat,
Bonita S Chester,
Byungja E Marciante,
Chaoying C Ma,
Christine M Smith,
Christopher Janik,
Connie Hannon Rabel,
Connie L Hannon Rabel,
Daniel J Lahar,
Darin S Wiegers,
David M Beltran,
Diane C Thibodeau,
Dien N Nguyen,
Dr. Jason R Caballero,
Edmund F Mrak, Jr,
Edward J Janik,
Erika V Butler,
Gabrielle J Swain,
Hang N Guo,
Ivis Lnegron Torres,
Joanne Heim,
Jonah S Ufferfilge,
Karen C Daugherty,
Kent A Conforti,
Latrecia D Stubbs,
Linda L Ng,
Linda Thai,
Lisa R Jennings,
Lisa R Whitt,
M Patriciaurphy Murphy,
Margaret M Annes,
Margaret M Sands,
Mark R Mcclain,
Matthew C Watson,
Maya M Davis,
Michele Perry Williams,
Michelle M Noe,
Muralidhara B Gavini, PhD,
Nealie C Newberger,
Niketa Patel,
Nina Yang,
Noreen Muniz,
Pauline N Logan,
Peter R Lenahan,
Philip M Steele, PhD,
Rapti D Madurawe,
Rebecca C O Bryan,
Robert C Steyert,
Rodney L Tinzie,
Sina Shojaee,
State Agency,
Stephanie Mangigian, MS/OSH, RN,
Stephen D Brown,
Stephen R Souza,
Susan F Laska, MS,
Theresa Kirkham (NMI),
Thomas J Arista,
Victoria M Daddeo,
Wei Huaemily Wu
Chunsheng Cai, PhD's Documents
Publish Date | Document Type | Title |
---|---|---|
July, 2017 | FDA 483 | Neos Therapeutics, LP - Form 483, 2017-07-25 |
July, 2018 | EIR | Pfizer Laboratories Div Pfizer Inc - EIR, 2018-07-18 |
July, 2018 | FDA 483 | Pfizer Laboratories Div Pfizer Inc - Form 483, 2018-07-18 |
February, 2020 | FDA 483 | Pfizer Manufacturing Deutschland GmbH - Form 483, 2020-02-07 |
Experience Redica System's NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more